Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy [Volume 37, Issue 3, September 2018, Pages 248–256]

In the above article (https://doi.org/10.23876/j.krcp.2018.37.3.248), there was an error in Figure 3. The authors regret this error, and the corrected figure is now presented below.

Figure 3.

Kaplan-Meier analysis of anti-PLA2R antibody level and probability of renal survival (chronic kidney disease stage ≥ 3) (A), cumulative probability of complete remission (B) and spontaneous remission (C).

Anti-PLA2R ab, anti-phospholipase A2 receptor antibody.

The authors would like to apologize for any inconvenience.